[Evaluation of regimens for the simultaneous and sequential administration of cytostatics in the combined chemotherapy of disseminated forms of breast cancer].
Fifty-eight patients with disseminated breast cancer were randomly divided into 2 study groups. All patients received 4-week courses of combination chemotherapy with vinblastine, thiotepa and 5-fluorouracil. In study group I, the drugs were injected simultaneously once a week, while, in study group II, the treatment schedule was as follows: vinblastine--on days 1 and 2, thiotepa--day 3 and 5-fluorouracil--on day 5, weekly. Leucopenia development was significantly more frequent in study group 2.